Geller, L. Et Al. 2013. Transseptal endocardial left ventricular lead implantation is safe and effective alternative of conventional resynchronisation therapy. Congress of the European-Society-of-Cardiology (ESC) , (Amsterdam, Netherlands), 588.

Geller, L., Molnar, L., Tahin, T., Szilagyi, S. Z., Zima, E., Szeplaki, G., ... Osztheimer, I.(2013). Transseptal endocardial left ventricular lead implantation is safe and effective alternative of conventional resynchronisation therapy . Congress of the European-Society-of-Cardiology (ESC) (pp.588). Amsterdam, Netherlands

Geller, L. Et Al. "Transseptal endocardial left ventricular lead implantation is safe and effective alternative of conventional resynchronisation therapy," Congress of the European-Society-of-Cardiology (ESC), Amsterdam, Netherlands, 2013

Geller, L. Et Al. "Transseptal endocardial left ventricular lead implantation is safe and effective alternative of conventional resynchronisation therapy." Congress of the European-Society-of-Cardiology (ESC) , Amsterdam, Netherlands, pp.588, 2013

Geller, L. Et Al. (2013) . "Transseptal endocardial left ventricular lead implantation is safe and effective alternative of conventional resynchronisation therapy." Congress of the European-Society-of-Cardiology (ESC) , Amsterdam, Netherlands, p.588.

@conferencepaper{conferencepaper, author={L. Geller Et Al. }, title={Transseptal endocardial left ventricular lead implantation is safe and effective alternative of conventional resynchronisation therapy}, congress name={Congress of the European-Society-of-Cardiology (ESC)}, city={Amsterdam}, country={Netherlands}, year={2013}, pages={588} }